Xcout Intel
GENEDRIVE PLC competitors & alternatives
The 12 closest competitors and alternatives to GENEDRIVE PLC among biotech companies — ranked by similarity to what GENEDRIVE PLC actually does, not by market-cap band.
Subscribe to see GENEDRIVE PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About GENEDRIVE PLC
Genedrive Plc, a molecular diagnostics firm established in Manchester, UK, in 2000 (and known as Epistem Holdings Plc until its name change in July 2016), focuses on developing and commercializing innovative point-of-care diagnostic platforms. These solutions cater to a range of applications, including the identification of infectious diseases, genetic profiling, and pathogen detection. At the core of their offerings is the proprietary Genedrive system, a compact polymerase chain reaction (PCR) technology. This advanced platform enables the rapid amplification and detection of nucleic acids from diverse biological samples, such as plasma, sputum, and buccal swabs. The Genedrive platform features several key diagnostic products: the Genedrive HCV ID Kit for qualitative Hepatitis C virus detection; the Genedrive BioPlex, designed for the quick identification of military biothreats from pathogens; and the Genedrive MT-RNR1-ID Kit, a rapid genetic test vital for emergency neonatal care. Complementing these is the Genedrive Connect app, an Android-based mobile application that streamlines data management and facilitates results transmission. Genedrive Plc serves the biotechnology and pharmaceutical sectors globally, with its reach extending throughout the United Kingdom, Europe, the United States, and other international regions. The company has also partnered with Beckman Coulter Life Sciences to automate laboratory PCR testing procedures for COVID-19.
GENEDRIVE PLC at a glance
GENEDRIVE PLC is a biotech company headquartered in Manchester, United Kingdom, founded in 2007. It is publicly listed (GDR) with a market capitalisation of $26.7M.
Top 12 GENEDRIVE PLC competitors
Ranked by semantic similarity — how close each company is to GENEDRIVE PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
GNA Biosolutions GmbH is a German biotechnology company developing rapid molecular-diagnostics systems, including instruments and consumables for automated nucleic-acid extraction and amplification. Its solutions are intended for applications such as clinical testing, research, and other settings requiring fast pathogen or genetic analysis.
Medical Diagnostics
Global BioDiagnostics Corp. (Bio-Diagnostics) researches, develops, and manufactures diagnostic products and provides laboratory testing services for dermatology, immunology, and immunohistochemistry. The company serves NHS and private clinics across the UK by supplying tools such as skin prick test accessories, patch testing ranges, autoimmune diagnostics, and rapid antibody testing solutions.
Similar biotech company
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Similar biotech company
GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Similar biotech company
Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolve challenges often associated with traditional molecular tools, such as antibodies, offering crucial solutions to bioprocessing, diagnostic, and pharmaceutical scientists. Established in 2014, the company primarily serves pharmaceutical corporations, diagnostic development firms, and various research institutes.
Similar biotech company
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offerings encompasses diagnostic tests and specialized instrumentation for identifying numerous infectious diseases. These include Lyme disease, sexually transmitted infections like syphilis and herpes, SARS-CoV-2, and a variety of viral pathogens such as Epstein Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella. Additionally, Trinity Biotech provides in-vitro diagnostic products centered on haemoglobin A1c for the crucial monitoring, diagnosis, and risk assessment of diabetes. The company's product development incorporates diverse assay formats, including immunofluorescence, enzyme-linked immunosorbent (ELISA), Western blot, and line immunoassays. It also supplies a suite of reagent products, including ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase, vital for diagnosing liver and kidney disorders, as well as haemolytic anaemia. Beyond diagnostics, Trinity Biotech serves the life sciences industry and research facilities by supplying raw materials. The company's customer base comprises public health authorities, non-governmental organizations, and both clinical and reference laboratories. Its products are distributed through a dedicated direct sales force, complemented by a broad network of independent distributors and strategic partnerships.
Biotechnology, Healthcare
Seegene provides molecular diagnostics products and technologies, including high-multiplex syndromic assays, automated instruments, and software systems. The company serves global healthcare and research partners by offering diagnostic solutions and a data platform for infectious disease detection and surveillance.
Biotechnology, Diagnostics, Healthcare
GenDx specializes in molecular diagnostics for transplantation and personalized healthcare, providing pre- and post-transplant reagents, NGS-based typing assays, and analysis software. The company serves diagnostic laboratories, transplant centers, and researchers by offering products and technical support for HLA typing, chimerism monitoring, and related applications.
Diagnostics
Genetic Analysis AS is a research-driven diagnostic company headquartered in Oslo, Norway, supplying high-quality diagnostics to the microbiome market.
Similar biotech company
Novacyt S.A., together with its associated entities, specializes in the research, production, contract design, and market launch of diagnostic solutions. These offerings are primarily developed for the detection of cancer and a range of infectious diseases. The company maintains an extensive international operational footprint, encompassing the United Kingdom, the broader European continent, the United States, the Asia Pacific region, the Middle East, and Africa. Its operations are segmented into three core divisions: Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment is dedicated to the conceptualization, manufacturing, and commercialization of molecular real-time qPCR testing equipment and corresponding reagents, specifically for infectious disease diagnostics. The Lab21 Products division focuses on the development, production, and supply of various protein-based in-vitro diagnostic (IVD) devices that target infectious illnesses. Meanwhile, IT-IS International is responsible for engineering and fabricating PCR devices utilized within both the life sciences and food testing industries. Novacyt serves a diverse client base, including healthcare institutions and corporate organizations. The company was established in 2006 and is headquartered in Vélizy-Villacoublay, France.
Diagnostics
Linear Diagnostics Limited, trading as ExGen Dx, is a next-generation near-patient diagnostics company located at the BioHub Birmingham in Birmingham, United Kingdom.
Similar biotech company
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of GENEDRIVE PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GENEDRIVE PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →